Document:

Exhibit 4.1

 

AMENDMENT
TO THE VAN HERK WARRANT

 

This
Amendment to the Van Herk Warrant (this “Amendment”) is entered into as of December 29, 2020 (the “Amendment
Date”), by Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”), Ospraie Ag Science
LLC (“Ospraie” or the “Lead Investor”) and Van Herk Investments B.V. (“Van Herk”).
Reference is made to (a) the Securities Purchase Agreement (the “SPA”), dated December 15, 2017 by and among
the Company and the investors referred to therein, and (b) the warrant to purchase 5,333,333 shares of Common Stock issued pursuant
to Section 1 of the SPA to Van Herk (the “Van Herk Warrant”). Capitalized terms used herein and not otherwise
defined shall have the definitions ascribed to such terms in the Van Herk Warrant.

 

RECITALS

 

WHEREAS,
pursuant to the terms of the Van Herk Warrant, the Van Herk Warrant may be amended with the written consent of the Required Holders;

 

WHEREAS,
the Lead Investor and Van Herk constitute the Required Holders;

 

WHEREAS,
the Company, Van Herk and the Lead Investor desire to amend the Van Herk Warrant as set forth herein;

 

NOW,
THEREFORE, in consideration of the premises, and for the consideration herein set forth the receipt of which is hereby acknowledged,
the parties hereby agree as follows:

 

AMENDMENT

 

	 	1.	Amendment
    to Section 1(b) of the Van Herk Warrant. Section 1 of the Van Herk Warrant is hereby amended by deleting the prior subsection
    (b) and replacing it with the following:

 

(b)
Exercise Price. For purposes of this Warrant, “Exercise Price” means (i) $0.96 per share for the first
1,777,778 Warrant Shares purchasable hereunder, (ii) $1.00 per share for the second 1,777,778 Warrant Shares purchasable hereunder,
and (iii) $1.04 per share for the last 1,777,777 Warrant Shares purchasable hereunder, in each case subject to adjustment as provided
in Sections 2(b), 2(c) or 2(d) herein.

 

	 	2.	Amendment
    to Section 1(d) of the Van Herk Warrant. Section 1 of the Van Herk Warrant is hereby amended by deleting the prior subsection
    (d) and replacing it with the following:

 

(d)
Cashless Exercise. Notwithstanding anything contained herein or the exercise notice attached hereto to the contrary, this
Warrant may not be exercised by “cashless” or “net” exercise.

 

	 	3.	Amendment
    to Section 2(a) of the Van Herk Warrant. Section 2 of the Van Herk Warrant is hereby amended by deleting the prior subsection
    (a) and replacing it with the following:

 

(a)
Adjustment Upon Issuance of Shares of Common Stock. [Reserved.]

 

    	 

    	 

    

 

	 	4.	Amendment
    to Section 14 of the Van Herk Warrant. Section 14 of the Van Herk Warrant is hereby amended by deleting the prior Section
    14 and replacing it with the following:

 

14.
TRANSFER; MARKET STAND-OFF. This Warrant may not be offered for sale, sold, transferred, pledged or assigned without the
consent of the Company. The Warrant Shares may be offered for sale, sold, transferred, pledged or assigned without the consent
of the Company, except as may otherwise be required by Section 11 of the Registration Rights Agreement. Notwithstanding the foregoing,
in order to induce the Company to enter into the Amendment, (A) the Holder hereby agrees that for each period (the “stand-off
periods”) of six (6) weeks following each of (i) Amendment Date, the Second Tranche Expiration Date and the Third Tranche
Expiration Date and (ii) any other date on which any Warrant Shares are acquired, the Holder shall not, without the prior written
consent of the Company, directly or indirectly, (i) offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose
of, any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common Stock (including, without
limitation, shares of Common Stock or any such securities which may be deemed to be beneficially owned by the undersigned in accordance
with the rules and regulations promulgated under the Securities Exchange Act of 1934, as the same may be amended or supplemented
from time to time (such shares or securities, the “Beneficially Owned Shares”)), (ii) enter into any swap,
hedge or other agreement or arrangement that transfers, in whole or in part, the economic risk of ownership of any Beneficially
Owned Shares, Common Stock or securities convertible into or exercisable or exchangeable for Common Stock, (iii) engage in any
short selling of any Beneficially Owned Shares, Common Stock or securities convertible into or exercisable or exchangeable for
Common Stock or (iv) enter into any transaction, other than the purchase of Warrant Shares or other acquisition of Common Stock,
that would require the filing with the U.S. Securities and Exchange Commission of a Form 4 statement regarding changes in beneficial
ownership of Company securities or a Form 144 regarding notice of proposed sale of Company securities, and (B) the Company may
maintain restrictive legends on Warrant Shares following any Warrant exercise during any stand-off period.

 

	 	5.	Amendment
    to Section 17(n) of the Van Herk Warrant. Section 17 of the Van Herk Warrant is hereby amended by deleting the prior subsection
    (n) and replacing it with the following:

 

(n)
“Expiration Date” means December 31, 2020, provided, however, that if the Holder exercises this Warrant with
respect to the purchase of at least 1,777,778 Warrant Shares on the Amendment Date and pays the Fee Reimbursement on the Amendment
Date, then the Expiration Date shall mean March 25, 2021 (the “Second Tranche Expiration Date”) with respect
to any Warrant Shares unexercised as of the Amendment Date, and provided further that if Holder also exercises this Warrant with
respect to the aggregate purchase of at least 3,555,556 Warrant Shares on or before March 25, 2021 (inclusive of any Warrant Shares
purchased on the Amendment Date), then the Expiration Date shall mean December 15, 2021 (the “Third Tranche Expiration
Date”) with respect to any Warrant Shares that remain unexercised as of March 25, 2021.

 

	 	6.	Amendment
    to Section 17(gg) of the Van Herk Warrant. Section 17 of the Van Herk Warrant is hereby amended by adding the following
    new Section 17(gg):

 

(gg)
“Fee Reimbursement” means $15,000 of immediately available funds payable to the Company by wire to an account
designated by the Company.

 

    	2

    	 

    

 

	 	7.	Miscellaneous
    Provisions.

 

	 	(a)	Governing
    Law. All questions concerning the construction, validity, enforcement and interpretation of this Amendment shall be governed
    by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or
    rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions
    other than the State of New York.
	 	 	 
	 	(b)	Ratification;
    No Further Amendment. Except as expressly amended hereby, all terms, conditions and provisions of the Van Herk Warrant
    shall remain unmodified and in full force and effect.
	 	 	 
	 	(c)	Effect
    of Amendment. This Amendment shall form a part of the Van Herk Warrant for all purposes. From and after the date of this
    Amendment, any reference in the Van Herk Warrant to “this Warrant”, “hereof”, “herein”,
    and “hereunder” and words or expressions of similar import shall refer to the Van Herk Warrant as amended by this
    Amendment. The provisions of Section 9 (Amendment and Waiver), Section 10 (Governing Law; Jurisdiction; Jury Trial) Section
    11 (Construction; Headings), Section 12 (Dispute Resolution), Section 13 (Remedies, Other Obligations, Breaches and Injunctive
    Relief) and Section 15 (Severability) of the Van Herk Warrant shall apply mutatis mutandis to this Amendment, and the
    Van Herk Warrant as amended by this Amendment, taken together as a single agreement, reflecting the terms therein as modified
    hereby.
	 	 	 
	 	(d)	Counterparts.
    This Amendment may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
    and shall become effective when counterparts have been signed by each party and delivered to the other party; provided
    that a facsimile or .pdf signature shall be considered due execution and shall be binding upon the signatory thereto with
    the same force and effect as if the signature were an original, not a facsimile or .pdf signature.

 

[Signature
Pages Follow]

 

    	3

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first above written.

 

	 	MARRONE
    BIO INNOVATIONS, INC.
	 	 	 
	 	By:
    	/s/
    Jim Boyd
	 	Name:	Jim
    Boyd
	 	Title:	
    Chief Financial Officer
	 	 	 
	 	OSPRAIE
    AG SCIENCE LLC
	 	 	 
	 	By:
    	/s/
                                         Jason Mraz

	 	Name:	Jason
    Mraz
	 	Title:	Authorized
    Signatory
	 	 	 
	 	VAN
    HERK INVESTMENTS B.V.
	 	 	 
	 	By:
    	/s/
    E.G.A. Esveld
	 	Name:	E.G.A.
Esveld
	 	Title:	Deputy 

 

    	4

    	 

    

 

[Signature
Page to Amendment to the Van Herk Warrant]

 

    	5Exhibit 10.1

 

FERRELLGAS, INC.

7500
College Boulevard

Overland
Park, KS 66213

 

December 29, 2020

 

VIA ELECTRONIC AND CERTIFIED MAIL

 

Jim Ferrell

[Personal contact information intentionally omitted]

 

RE:       Offer
Letter and Signing Bonus 

 

Dear Jim:

 

It is my pleasure to extend the following
offer of employment to you on behalf of Ferrellgas, Inc. (the “Company”), subject to the terms and conditions outlined
below:

 

Title:
President and Chief Executive Officer

 

Reporting
Relationship: The position will report to the Board of Directors

 

Location:
The position will work out of the Company’s headquarter office at 7500 College Boulevard, Overland Park, KS 66213

 

Start
Date: December 31, 2020

 

Base
Annual Salary: $900,000 per year less applicable taxes and withholdings

 

Signing
Bonus: A one-time payment of $2,000,000 subject to applicable taxes and withholdings. This payment is payable upon the
signing of this Offer Letter, the Employment Agreement, and the Confidentiality and Restrictive Covenants Agreement

 

Incentive
Plan: Upon accepting this offer and signing the Agreements outlined above, you will be eligible to participate in the
Company’s Short Term Incentive Plan subject to the terms and conditions outlined in the Plan

 

Benefits:
You will be eligible for medical, dental and vision benefits provided by the Company

 

Paid
Time Off: You will receive twenty-five (25) days of paid time off capped at 200 hours per year.

 

Travel:
If you travel on behalf of the Company, your travel expenses will be reimbursed.

 

     

     

    

 

This letter agreement
contains all of the understandings and representations between the Company and you relating to your offer of employment. This letter
agreement, for all purposes, shall be construed in accordance with the laws of the State of Kansas without regard to conflicts-of-law
principles.

 

	 	Very truly yours,
	 	Ferrellgas, Inc.
	 	 
	 	 
	 	By:	 /s/ Jordan Burns
	 	 	Name: Jordan Burns
	 	 	Title: VP and General Counsel

 

	Agreed to and accepted:	 
	 	 
	 	 
	By: 	/s/ James E. Ferrell	 
	 	James E. Ferrell	 
	 	 
	Date:	December 30, 2020

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]